… preclinical alpha-synuclein PD model (milestone). Impact on Diagnosis/Treatment of Parkinson’s disease:  The … aspects of PD are an important focus of applied research and the STING inhibitors we develop could become … Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies …

… symptoms has not been the focus of Parkinson’s disease research though psychiatric symptoms can be just as … Additional physiological measurements will provide insight into how the circuits are able to normalize network activity across the brain. Impact on Diagnosis/Treatment of Parkinson’s Disease:  This project …

… activity in live cells could help provide an earlier diagnosis of PD and predict disease progression, as well as … probes and identify the best probe molecule to advance into further testing. Finally, we will develop a suitable … of this protein in cells from those with PD. Impact on Diagnosis/Treatment of Parkinson's disease: We expect that …

… This grant builds upon the research from a prior grant: Novel Quantification Paradigm … neuroanatomic changes is expected to provide novel insights into the relationship between changes in dopamine and PD … techniques. In addition to aiding in the identification of early disease, these techniques, if successful, will be …

… This grant builds upon the research from a prior grant: PET Imaging Probe Development … molecules in a short period of time and introduce diversity into the potential tracers in development. Once the team has … A tracer for imaging alpha-synuclein mRNA could improve early diagnostic accuracy for Parkinson's. Furthermore, …

… disease and (ii) an identification of a possible target for early diagnosis and disease modifying therapies. Project … ex-vivo pre-clinical models studies suggest that a possible early signature of the LRRK2 mutation-related Parkinson’s … MJFF Research Grant …